GLP-1 sales forecast increased to $150B at TD Cowen
Source: SeekingAlpha
2026-06-05 10:22:45 ET
More on Eli Lilly, Novo Nordisk A/S
- Eli Lilly and Company (LLY) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
- Eli Lilly Expands Into Infectious Diseases, Retatrutide Adds Another Phase 3 Win
- Wall Street Underestimates Novo Nordisk's GLP-1 Comeback
- Lilly halving planned €2.3B investment in Germany: CEO
- Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Read the full article on Seeking Alpha
For further details see:
GLP-1 sales forecast increased to $150B at TD Cowen
Structure Therapeutics Inc.
NASDAQ: GPCR
GPCR Trading
-2.93% G/L:
$38.05 Last:
159,868 Volume:
$38.71 Open:
GPCR Latest News
June 05, 2026 04:05:00 pm
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity
May 26, 2026 04:05:00 pm
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
May 24, 2026 10:39:48 am
This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million
GPCR Stock Data
$5,430,883,453
65,267,397
0.07%
67
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
